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Abstract.  To elucidate the structural basis for mem- 
brane attachment of the ot subunit of the stimulatory 
G protein (Gsot), mutant Gsu cDNAs with deletions 
of amino acid residues in the amino and/or carboxy 
termini were transiently  expressed in COS-7 cells. The 
particulate and soluble fractions prepared from these 
cells were analyzed by immunoblot using peptide spe- 
cific antibodies to monitor distribution of the expressed 
proteins.  Transfection of mutant forms of Gso~ with ei- 
ther 26 amino terminal  residues deleted (A3-28) or 
with 59 amino terminal  residues deleted (A1-59)  re- 
suited in immunoreactive proteins which localized pri- 
marily to the particulate  fraction.  Similarly,  mutants 
with  10 (A385-394),  32 (A353-384),  or 42 (A353-394) 
amino acid residues deleted from the carboxy terminus 
also localized to the particulate fraction,  as did a mu- 
tant form of Gsc~ lacking amino acid residues at both 
the amino and carboxy termini  (A3-28)/(A353-384). 
Mutant and wild type forms of Gsot demonstrated a 
similar degree of tightness in their binding to mem- 
branes as demonstrated by treatment with 2.5 M  NaCI 
or 6 M  urea, but some mutant forms were relatively 
resistant compared with wild type Gsc~ to solubiliza- 
tion by 15 mM NaOH or 1%  sodium cholate. We con- 
clude that:  (a) deletion of significant portions of the 
amino and/or carboxyl terminus of Gsc~ is still com- 
patible with protein expression;  (b) deletion of these 
regions is insufficient to cause cytosolic localization of 
the expressed protein.  The basis of Gsc~ membrane 
targeting  remains to be elucidated. 
UANINE nucleotide  binding  proteins  (G  proteins) 1 
involved  in  signal  transduction  are  heterotrimers 
composed of a GTP-binding  ct subunit and a/33, sub- 
unit complex. G proteins constitute one family in the GTP- 
binding  protein superfamily  (5, 6,  14, 22, 24).  The G pro- 
teins transduce extracellular  signals into intracellular  effects 
by transferring  the information received by various receptors 
for hormones,  photons and odorants,  to effectors  such  as 
adenylyl cyclase for the stimulatory G protein (Gs) and in- 
hibitory G proteins (Gi),  cGMP phosphodiesterase for ret- 
inal  transducin,  and phospholipases and ion channels  for 
other G proteins.  The specificity  of receptor-effector cou- 
pling results primarily from the a  subunit.  G protein c~ sub- 
units are known to be localized to the cytosolic face of the 
plasma membrane.  The c~ subunits,  with the exception  of 
transducin,  are tightly bound to the membrane, so that deter- 
gents are required to release them (37). However, the c~ sub- 
unit amino acid sequences contain no hydrophobic mem- 
brane spanning  domains to account for their  attachment. 
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Posttranslational  modification  of proteins  with lipids  is 
one way to increase the hydrophobicity of the molecules and 
thus promote membrane association (38).  Fatty acylation 
with myristate was found in the ot subunits of Gi and Go (9), 
and failure of membrane attachment  was observed with mu- 
tant forms (substitution  of alanine for glycine in position 2) 
of Gi (18) and Go (27) which were incapable  of undergoing 
N-myristoylation.  Isoprenylation  is  another  type of lipid 
modification observed in G proteins,  The "y subunit of trans- 
ducin was found to be modified by farnesylation  (12, 23) and 
the 3' subunit  of neural  G proteins by geranylgeranylation 
(26, 39). A mutant 3' subunit lacking this lipid modification 
lost its ability to target to the membrane (35).  However, no 
such lipid modification  has been observed in the ot subunit 
of Gs (Gsa), nor was it found to contain either myristate or 
palmitate  (9).  Thus  the molecular mechanism  of its  an- 
chorage to the membranes remains unclear. 
Sternweis  (36) suggested that the ot subunit might be an- 
chored to the membrane by the ~'y subunit complex, which 
is more hydrophobic  and  incorporates  spontaneously into 
phospholipid vesicles.  The c~ subunit  of G proteins is be- 
lieved to be separated from the ~3" subunit complex when it 
is activated  by receptors or GTP analogs  such as GTP3"S. 
Gsa  was  observed to  remain  membrane  associated even 
upon activation.  There is some evidence for translocation  of 
Gsot from the membrane after agonist treatment of cells (32), 
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able GTP analogs was needed before significant release of 
Gsa from the membrane was observed (25). These observa- 
tions argue against a simple model of Gsot anchorage by the 
~3' complex. Therefore, other mechanisms are needed to ex- 
plain the tight binding of Gsot to the membrane. 
In an effort to determine which Gsot domains are essential 
for membrane binding, we constructed mutant forms of Gso~ 
with deletions in the amino terminal, carboxy terminal, or 
both terminal sequences using the polymerase chain reaction 
(PCR).  The mutants  were expressed in COS cells, and the 
intracellular localization of the mutated proteins was deter- 
mined by  separating  the cells into particulate  and soluble 
fractions,  and  immunoblotting  with  peptide-specific  anti- 
bodies. 
Materials and Methods 
Construction of  Mutant Gs~s 
The cDNAs coding for rat Gsa (17) were kindly provided by Dr. R. R. Reed 
(Johns Hopkins University, Baltimore, MD),  and both the 47-kD Gsc~-i 
containing 394 amino acid residues, and the 42-kD Gs~-3 containing 379 
residues (8), were cloned into the pCD-PS vector which contains simian 
virus 40-derived DNA sequences permitting expression of cloned genes in 
eukaryotes (4). The deletion mutants of Gse~ were constructed  using the 
PCR, and the schematic map of deletions in the Gsa mutants is shown in 
Fig. 1. The oligonucleotide primers for PCR were synthesized with a DNA 
synthesizer (model 380B; Applied Biosystems, Foster City, CA), and the 
tritylated oligomers were purified on NENsorb  Prep columns (New En- 
gland Nuclear, Du Pont, Boston, MA). The reaction mixture contained 10 
mM Tris-C1, pH 8.4, 50 mM KC1, 100 txg/ml gelatin,  2--4 mM MgCI2, 
200 ~M of each deoxyribonucleotide triphosphate,  25 pmol of each up- 
stream and downstream oligonucleotide primer, 200 ng template DNA, and 
1.25 U of Thermus aquaticus (Taq) polymerase (Perkin-Elmer Cetus, Nor- 
walk, CT) in a total volume of 50 t4.25 cycles consisting of denaturation 
at 96~  for 1 rain, annealing at 45~  for 1 min, and primer extension at 
72~  for 3 min were performed, followed by one final extension reaction. 
The PCR products were analyzed by agarose gel electrophoresis, and DNA 
of the proper  size was recovered from the gel. 
(A3-28)Gsc~-1. The nucleotide sequences coding for the amino terminal 
26 residues from Cys-3 to Lys-28 were deleted from the cDNA of Gsa-1 
to construct (A3-28)Gsa-1. The sequence of the 5' primer was Y-TAT AAC 
GGC CGA TC~ GCC AGC TGC AGA AGG-3', and was designed to con- 
tain a  restriction  site  for XmalII,  codons  for the first two amino  acid 
residues of Gsc~, and then that for Gin-29 to delete the nucleotide sequences 
coding for the intervening 26 amino acid residues. The 3' primer, 5'-ATG 
AAG TAC TTG GCC CGG-Y, complementary to the wild type Gsa-1 se- 
quence, was positioned downstream to the restriction site for MluI. The 
PCR was performed using Gs~-I cDNA in pCD plasmid, pCD-Gsc~-I, as 
the template. The purified mutant PCR fragment was then ligated into pCD- 
Gsa-1 in place of the wild type sequence using the single recognition sites 
for XmalIl and MluI. 
(A3-28)Gsc~-3. The same nucleotide sequence deleted in (h3-28)Gsa-1 
was also deleted in Gsa-3 by using the same oligonucleotide primers but 
with pCD-Gsa-3 as the template DNA. 
(&1-59)Gsa-1.  A novel cDNA (16) of canine Gsa-1 coding for the se- 
quences from the second initiation site, Met-60, was a generous gift from 
Dr.  Yoshihiro Ishikawa (Massachusetts General  Hospital,  Boston,  MA). 
The  cDNA  insert  was  cloned  into  the  pCD-PS  plasmid  to  construct 
pCD-(A1-59)Gsa-1. 
(A385-394)Gsc~-3. The carboxy terminal 10 residues from Gsc~-3 were 
deleted using PCR to construct (A385-394) Gsa-3.  Note that throughout 
the paper we number Gs~ residues based on the length (394 amino acids) 
of Gsc~-I (8).  Thus,  for example, we designate the mutant in which the 
carboxy-terminal decapeptide of Gsa-3 is deleted (A385-394)Gsa-3.  The 
sequence of  the 3' primer was 5'-TCA ACT CTT AAG TTA CTG GAT GAT 
GTC ACG GCA-3', which contains the sequence coding from Cys-379 to 
Gln-384 followed by a termination codon and the recognition site for Aflll. 
The 5' primer, 5"CCG CAG CCC GGC CGC GCC CCG CCG CCG A'rG- 
3', was a wild type sequence upstream to the restriction site of XmalII. The 
mutant PCR fragment was ligated into the pCD-Gsc~-3  at the unique restric- 
tion sites for XmalII and AfllI. 
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Figure  1.  Schematic  map  of 
the wild type and mutant forms 
of Gsa. The hatched bars rep- 
resent the deleted amino acid 
residues, and the numbers in- 
dicate the first or last residue 
of the deletion. Residues 72- 
86 correspond to the alterna- 
tively spliced portion of Gsa 
(8). Gsa-1 and Gsa-3 refer to 
2 of the 4 forms derived by al- 
ternative splicing (8), and have 
394 and 379 residues, respec- 
tively.  The  scale  at  bottom, 
and the numbering for all mu- 
tants  throughout  the  paper, 
use  the  number  of  residues 
found in Gsa-l. 
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of Gs~-3 was made by removing the sequence coding for 32 amino acid 
residues from Gly-353 to Gln-384 to construct (A353-384)Gsa-3. The 3' 
primer used to make the deletion was a 60-mer, 5"TCA ACT CTT AAG 
TTA GAG CAG CTC GTA TTG GCG AAG ATG CAT GCG ACT AGC 
AGT GCT GAT-3'. It contained the sequences for six amino acid residues 
upstream to  the deletion,  10  carboxy terminal residues,  a  termination 
codon, and the restriction site for AfllI, sequentially. The 5' primer was the 
same as that used in constructing (A385-394)Gsa-3. The PCR product and 
wild type Gs~-3-containing plasmid were cut with XmalII and AfllI, and 
then ligated with I"4 DNA iigase. 
(A353-394)Gs~-3.  The carboxy terminal 42 residues, from Gly-353 to 
Leu-394, were deleted using PCR. The 3' primer was 5'-TCA  ACT CTT 
AAG TTA ACT AGC AGT GCT GAT-3', which contained the sequences 
for six amino acids upstream to the deletion, a termination codon, and the 
restriction site for AfllI. The 5' primer was the same as that employed in 
construction of (A385-394)Gsa-3.  The PCR product was digested with 
XmalIl and Aflll, and then ligated to the wild type cDNA prepared by diges- 
tion with the same enzymes. 
(&3-28/A353-384)Gsu-3.  A double deletion mutant was constructed by 
ligating the XmalII-MluI fragment of (A3-28)Gs~t-3 into the plasmid con- 
taining (A353-384)Gsc~-3. 
Preparation of  Mutant Gsc~ DNA 
A competent Escherichia coil strain DH5ot (Bethesda Research Laborato- 
ties, Gaithersburg, MD) was transformed with the ligation mixture of vari- 
ous mutants and the transformed cell colonies were selected on an LB agar 
plate containing 100 #g/ml ampicillin. Plasmid DNA purified from each 
colony was analyzed with the proper restriction enzyme to screen for the 
specific mutant Gsct DNA. DNA from positive clones was then sequenced 
using the dideoxynucleotide chain termination method to insure the correct 
mutation (33).  Plasmids were purified using a  cesium chloride gradient 
method (33). 
Expression of Deleted Forms of Gsa in COS Cells and 
Preparation of the Cell Fractions 
Transformed monkey kidney cells, COS-'/, were transfected with the pCD- 
PS plasmid with and without the cDNA of wild type and mutated Gsa by 
the DEAE-dextran method (10). COS-'/cells were maintained in DME with 
10%  FCS,  100 U/nil penicillin, and  100 ttg/rni streptomycin (Biofluids, 
Rockville, MD). 
After 48 hours the transfected COS cells were harvested, pelleted and 
resuspended in four volumes of homogenization  buffer composed of  20 mM 
Tris-Cl, pH 8.0, 1 mM PMSF, 1 mM EDTA, 10 #g/ml leupeptin, 1 #g/ml 
aprotinin, and 1 mM DTT. The cells were homogenized by passing through 
a 25-guage needle 15 times. The cell lysate was centrifuged at 600 g for 
5 rain, and the supernatant was centrifuged at 100,000 g for 60 rain at 4~ 
The resulting supernatant was transferred to a fresh tube, the pellet was sus- 
pended in the original volume of buffer,  and both fractions were recen- 
trifuged and separated. The washed pellet was resuspended in three volumes 
of the homogenization buffer and designated as the particulate (P) fraction, 
and the supernatant was designated as the soluble (S) fraction. 
The protein concentration was determined by the dye binding method (7) 
with  BSA  (Bio-Rad  Laboratories,  Cambridge,  MA)  as  the  reference 
standard. 
Treatment of the Particulate Fraction with Salts and 
Sodium Hydroxide 
The particulate fraction of the COS cells was centrifuged at 430,000 g for 
15 min at 4~  in a TLA100-2 rotor (Beckman Instruments Inc., Palo Alto, 
CA), and the pellet was resuspended in homogenization buffer. Approxi- 
mately 75-#g atiquots of the suspension were treated for 20 min with dis- 
tilled water at 4~  (control), or 2.5 M NaCl at 4~  or 6 M urea at 37~ 
each to a final volume of'~50 #l. The samples were centrifuged at 430,000  g 
for 15 min to prepare the pellet and the supernatant. The same quantity of 
the particulate fraction was treated with 15 mM sodium hydroxide solution 
containing 2 mM EDTA and 0.2 mM DTT, and the sample was centrifuged 
immediately, followed by neutralization of each fraction as described (2). 
Solubilization  of Various Forms of Gsa with 
Sodium Cholate 
100-t~g aliquots of  the particulate fraction of COS-7 ceils expressing various 
mutant forms of  Gsa were resuspended in homogenization  buffer containing 
1% (wt/vol) sodium cholate and incubated at 25"C for 1 h. The mixture was 
centrifuged at 100,000  g for 1 h to prepare pellet and soluble fractions. 
SDS-PAGE and Immunoblot 
Protein  samples  were  solubilized  and  separated  on  12.5%  or  15% 
SDS-polyacrytamide gels, and then transferred onto nitrocellulose paper 
(31). The wild type and mutant Gstx proteins were detected with the peptide 
specific antibodies, RM and GCL. The RM antibody was generated against 
the carboxy terminal decapeptide of Gsct (34),  and GCL was generated 
against the amino terminal 16 residues from Gly-2 to Lys-17. The Gstx was 
visualized by treating the blot either with peroxidase labeled secondary anti- 
body, or with [12SI]protein A  followed by autoradiography (13). 
Results 
Amino Terminal Deletion Mutants of  Gsu 
To evaluate the expression and membrane targeting of vari- 
ous deletion mutants of Gsot, we transfected COS cells with 
cDNAs and measured specific immunoreactivity in particu- 
late and soluble fractions. The COS cell fractions were pre- 
pared by ultracentrifugation of the cell lysate, followed by 
washing each  fraction  to  minimize cross  contamination. 
When the untransfected COS  cells were fractionated and 
analyzed by SDS-PAGE and western blot, two forms of en- 
dogenous Gsa, principally localized to the particulate frac- 
tion, were visualized at 47 and 42 kD, respectively. These 
correspond to the known splice variants of Gsct (8). The 47- 
kD band was less dense than the 42-kD band, and it some- 
times resolved into two bands indicating that this fraction 
was likely composed of Gst~-I and Gso~-2 (8).  Endogenous 
immunoreactivity is unchanged (Fig. 2) after mock transfec- 
tion or transfection with vector alone (pCD-PS).  Transfec- 
tion of the cells with wild type Gsct-1 resulted in an increase 
in the density of  the lower portion of  the 47-kD band, demon- 
strafing that the Gsot-1 had been overexpressed after transfec- 
tion (Fig. 2, left). 
The  nucleotide  sequence  coding  for  26  amino  acid 
residues from Cys-3 to Lys-28 was deleted from the cDNA 
of rat Gsct-1 to construct (A3-28)Gso~-1, and the cDNA was 
cloned into the pCD-PS vector for transfection into COS-7 
cells. We chose to delete this portion of Gsa since the amino 
terminus has been implicated in a  subunit membrane bind- 
ing and interaction with the/~/3' complex (20, 28, 29). The 
cells transfected with pCD-(A3-28)Gsot-1  exhibited a new 
band, which was resolved narrowly from the 42-kD protein 
and detected only with the carboxy terminal antibody, RM, 
but not with amino terminal antibody, GCL. This new band 
of (A3-28)Gsa-1  protein was visualized in the particulate 
fraction of the transfected COS cells, and a faint band was 
detected in the soluble fraction (Fig. 2, left). The soluble 
fraction of the cells transfected with wild type Gsc~ cDNA 
also contained a small amount of wild type Gso~, suggesting 
that the mutant Gsa was membrane associated to a degree 
similar to the wild type. Since the total mass of protein was 
generally more than twice as great in the particulate fraction 
as in the cytosol, and since a proportionately greater amount 
of the total membrane protein was comprised of Gso~, the 
vast majority of (A3-28)Gsct-1  protein localized to the par- 
ticulate fraction. In addition to the major ~41.5-kD  (A3- 
28)Gsc~-1 protein, two bands were detected with RM anti- 
body (but not GCL) at 38 and 34 kD. These lower molecular 
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ysis of the amino terminal de- 
leted forms of Gsu in trans- 
fected COS cells.  The COS 
cells were transfected without 
DNA  (Mock),  vector  only 
(pCD-PS),  wild  type Gsa-I 
(WT), (A3-28)Gsot-1, (A3-28)- 
Gstx-3, and (A1-59)Gsot-I by 
the  DEAE-dextran  method. 
The particulate  fraction  (P) 
and  the  soluble  fraction  (S) 
were prepared from the COS cells by centrifuging the 600 g supernatant at 100,000 g for 60 min separation and repeat centrifugation. 
50 t~g of protein was separated by 12.5  % SDS-PAGE  and transferred onto nitrocellulose paper. The blot was incubated with RM antibody 
directed against the carboxy terminal decapeptide, and then with peroxidase labeled goat anti-rabbit IgG antibody. The Gsa was then visual- 
ized by incubating the blot with the substrate mixture containing hydrogen peroxide and 4-chlom-l-naphthol. The upper arrows indicate 
the deletion mutant Gs~x proteins, and the lower arrows indicate proteins presumptively originating by translation from downstream initia- 
tion sites. 
weight bands were also observed on the blot of COS cells 
transfected with wild type GsoL-1, indicating that these pro- 
teins were not specific to the mutant Gsot. The bands at 38 
and 34 kD most likely correspond to Gsot-1 proteins in which 
synthesis has  started at the second,  Met-60, or the third, 
Met-110,  initiation codon, respectively. 
Since (A3-28)Gsct-1 was poorly resolved from the endog- 
enous 42-kD form of Gsot, we deleted the same 26 amino ter- 
minal residues (from Cys-3 to Lys-28) from the 42 kD Gsc~- 
3, and the deletion mutant was expressed in COS cells. Cells 
transfected with wild type Gs~x-3 showed increased expres- 
sion of the 42-kD band predominantly but not exclusively 
localized to the membrane (Fig.  2,  center;  the  relatively 
large proportion of wild type Gsc~-3 seen in this figure was 
not typical of most experiments). Cells transfected with the 
Gso~-3 amino-terminal deletion mutant ([A3-28]Gsot-3) ex- 
hibited,  in addition to the two endogenous forms of Gstx, 
three new proteins with molecular masses of 39, 37, and 34 
kD on SDS-PAGE (Fig. 2, center). These three proteins were 
detected with RM antibody but could not be detected with 
GCL antibody directed against amino terminal residues. Of 
these, the predominant one at 39 kD most likely represents 
the (A3-28)Gset-3 deletion mutant. The 37- and 34-kD bands 
presumably represent Gsa-3 proteins which use the second 
Met-60 or the third Met-110 as the initiation codon in their 
translation. The lower of these two bands comigrated with 
the 34-kD protein expressed in the (A3-28)Gsot-1 transfected 
cells,  as  would be predicted by a  common initiation  site 
downstream of the alternatively spliced residues 72-86 (8). 
Most of the  (A3-28)Gstx-3  expressed in  the COS  cells 
localized to the particulate fraction, though a small fraction 
was  also  visualized  in  the  soluble  fraction,  as  with  the 
(h3-28)Gsot-1  protein  and  the  wild  type  Gstx  subunits. 
These results showed that deletion of the amino terminal 26 
residues did not lead to cytosolic localization of  either Gs~-I 
or Gsot-3. 
A novel eDNA (16) of canine Gsa, (A1-59)Gsot-1,  which 
codes for the amino acid sequence beginning with the second 
initiation codon, Met-60,  was transfected into COS cells. 
The immunoblot of these cell fractions exhibited two new 
bands with molecular masses of 38 and 34 kD in addition 
to the two endogenous forms of Gsot (Fig. 3, right). The 38- 
kD protein was visualized only with RM antibody, and was 
not detected with GCL antibody (Fig. 3, lane/). This 38-kD 
protein comigrates with the 38-kD band found in COS cells 
transfected with the wild type or (A3-28)Gsot-1 and probably 
reflects translation initiation at Met-60.  The (A1-59)Gscx-1 
protein expressed in the COS cells localized to the particu- 
late fraction to approximately the same extent as the other 
mutants. Thus, the large deletion which includes part of the 
Figure 3. Reactivity of (A1-59)Gsc~-l, (A385-394)Gso~-3,  and (A3- 
28/A353-384)Gstx-3 with RM and GCL antibody. The particulate 
fraction of the COS cells transfected with (1) (AI-59)Gsc~-l, (2) 
(A385-394)Gs~-3,  and  (3)  (A3-28/A353-384)Gsa-3,  were  sep- 
arated on 12.5 % SDS-PAGE  and immunoblotted with RM antibody 
directed against the carboxy terminal decapeptides or GCL anti- 
body directed against the amino terminal 16 residues. The Gsa was 
visualized by incubating the blot with [125I]protein  A, followed by 
autoradiography. Under the conditions we employed, RM is sig- 
nificantly more sensitive than GCL (note that the latter, for exam- 
ple, barely detects the endogenous upper form of Gset). 
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calization. 
Carboxy-terminal Mutants 
V8  protease  digestion  of  $49  celt  membranes  has  been 
reported to release Gso~ from the membrane to the soluble 
fraction, and this has been ascribed to a critical protease- 
sensitive region near the carboxy terminus (1). We therefore 
chose to delete portions of the carboxy terminus to evaluate 
their contribution to Gs~ membrane localization. The car- 
boxy terminal  I0 residues from Arg-384 to Leu-394 were 
deleted from 42-kD Gs~-3 to construct (A385-394)Gs~-3, 
and COS cell expression was again used to assess membrane 
localization. The transfected ceils expressed the mutant Gs~ 
as a 40-kD protein (Fig. 4), which was visualized with GCL 
antibody directed against the amino terminal residues, but 
not  with  RM  antibody  generated  against  the  carboxy 
decapeptide deleted in this mutant (Fig. 3, lane 2). The ma- 
jor portion of the (A385-394)Gsot-3 protein was localized to 
the particulate fraction, demonstrating that deletion of the 10 
carboxy terminal residues of Gs~ does not cause cytosolic 
localization of the protein. 
A deletion near, but not including, the carboxy terminus 
was made by removing 32 residues from Arg-353 to Gin-384 
to prepare  (A353-384)Gs~-3.  COS  cells transfected with 
this construct expressed a 38-kD protein (Fig. 4). This band 
was visualized by both RM and GCL antibodies. The (A353- 
384)Gsot protein was localized primarily to the particulate 
fraction. The carboxy terminal 42 residues from Arg-353 to 
Leu-394 were deleted to construct (A353-394)Gsc~-3. COS 
cells transfected with this mutant were observed to express 
a 36-kD protein on immunoblots with GCL antibody (Fig. 
Figure 4. Immunoblot analysis of carboxy terminal deletion mu- 
tants of Gsc~ transfected in COS cells. 100/xg of protein from the 
particulate (P) and the soluble (S) fraction were separated by SDS- 
PAGE and immunoblotted with GCL antibody directed against the 
amino terminal 16 residues. The Gsa was visualized by incubating 
the blot with [~25I]protein  A followed by autoradiography. 
Figure 5.  Immunoblot  analysis of (A3-28/A353-384)Gsa-3  ex- 
pressed in COS cells by transfection. 50 #g of  protein from the par- 
ticulate (P) and the soluble (S) fraction were separated on 15% 
SDS-PAGE and transferred onto nitrocellulose paper. The blot was 
incubated with RM antibody directed against the carboxy terminal 
decapeptide, and the Gsc~  was visualized by incubating the blot with 
[t25I]protein A followed by autoradiography. The upper arrow in- 
dicates the double deletion mutant form of Gsa, and the lower ar- 
row indicates protein presumptively originating from a downstream 
initiation site. 
4). The expressed (A353-394)Gsot-3 protein was still local- 
ized to the particulate fraction. 
A Double Deletion Mutant 
Since some models of the 3-D structure of an c~ subunit sug- 
gest that the amino- and carboxy-termini are in close prox- 
imity and are oriented toward the plasma membrane (3), we 
made a double deletion mutant of Gsot-3 that combined the 
deletion of the 26 amino terminal residues,  from Cys-3 to 
Lys-28, and the deletion of the 32 residues near the carboxy- 
terminus, from Gly-353 to Gln-384. We reasoned that lack 
of  both the amino terminal and the carboxy terminal residues 
may cause Gso~  to localize to the cytosol. Preservation of the 
last 10 amino acids permitted detection of the mutant protein 
with  RM  antibodies.  When  the  double  deletion  mutant, 
(A3-28/A353-384)Gsot-3, was expressed in the COS cells 
by transfection, a major new band migrating at 34 kD was 
visualized with RM  antibody (Fig.  5,  right).  This protein 
could not be detected with GCL antibody (Fig.  3, lane 3). 
The double deletion mutant Gso~ was mainly localized to the 
particulate fraction, indicating that even the loss of residues 
at the amino and near the carboxy terminus does not cause 
cytosolic localization. 
Characterization of  Gs~ Membrane Binding 
To assess further the membrane binding of the deletion mu- 
tant Gsc~ proteins, the particulate fractions of the COS cells 
transfected with the (A3-28/A353-384)Gsot-3 cDNA were 
treated with 2.5 M NaC1, 6 M urea, or 15 mM NaOH (Fig. 
6). This concentration of NaC1 is enough to release loosely 
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particulate  fraction  of  COS 
cells transfected with (A3-28/ 
A353-384)Gsu-3  with  salts 
and  sodium  hydroxide.  The 
particulate fraction, 75/~g to- 
tal protein,  was treated  with 
2.5  M sodium chloride,  6 M 
urea,  or  15 mM sodium  hy- 
droxide, and the preparations 
were centrifuged at 430,000 g 
for 15 min to separate the pel- 
let  (P)  and  the  supernatant 
(S).  The samples  were  ana- 
lyzed as indicated in the leg- 
end of Fig. 5. Arrows indicate 
proteins described  in Fig. 5. 
bound  proteins,  including  peripheral  membrane proteins, 
but little of the endogenous wild type and none of the mu- 
tated Gsa protein was released by this treatment. When the 
particulate fractions were incubated with urea at 37~  about 
half of the endogenous Gsot immunoreactivity localized to 
the soluble fractions, whereas much less of the mutant pro- 
tein was released. Treatment of the particulate fraction with 
sodium hydroxide released most of the endogenous forms of 
Gsa, but only a  small proportion of the mutant protein. 
To analyze the solubility of the various mutant forms of 
Gsc~ expressed in COS cells, the particulate fractions were 
subjected to extraction with the detergent cholate.  Sodium 
cholate has been used to solubilize G protein a  subunits from 
membranes in the initial step of purification (37).  At least 
half of the endogenous forms of Gsot were extracted into the 
detergent phase under  the conditions we used.  The trans- 
fected wild type Gst~-3  showed slightly  less extractability 
(Fig.  7, lane 2). Compared with endogenous, wild type Gsa-3, 
all the deletion mutants showed a reduction in susceptibility 
to cholate solubilization. The carboxy terminal deletion mu- 
tants were substantially more resistant to solubilization by 
cholate than amino terminal deletion mutants (Fig.  7). 
Discussion 
G  protein ot subunits including Gs are tightly bound to the 
cell  membrane  despite  lacking  hydrophobic,  membrane- 
spanning domains. For pertussis toxin-sensitive ~  subunits 
including the various forms of Gi and Go, the amino termi- 
nus,  site of co-translational myristoylation, appears to be 
critical for membrane targeting (I1, 18, 27). Since Gsa does 
not undergo myristoylation, the mechanism of its membrane 
attachment is unclear. Using a reconstitution assay involving 
binding  of in  vitro translated  u  subunits  to  Gsot-deficient 
CYC- membranes, Audigier and co-workers (1, 20) showed 
that deletion of amino-terminal residues 2-29 from Gsa did 
not  prevent  binding  of the  in  vitro  translated  protein  to 
CYC- membranes.  Treatment of reconstituted  membranes 
with V8 protease released a soluble 43-kD fragment of Gsot. 
The authors  interpreted these results as defining  a  critical 
role for the carboxy terminus of Gsot in membrane binding, 
but direct evidence, including sequence identification of the 
proteolytic fragment,  was not provided (1). In work pub- 
lished (21)  after the present paper was first submitted,  the 
same  authors  provided  evidence  for  a  critical  role  for 
Figure  7.  Solubitization  of 
various forms of  Gsa from the 
particulate  fraction  of  COS 
cells with sodium cholate. The 
particulate  fraction  of  COS 
cells transfected with (1) vec- 
tor alone; (2) wild type Gsc~-3; 
(3) (A3-28)Gs~-3; (4) (A1-59)- 
Gsc~-l; (5) (A353-384)Gsct-3; 
(6) (A353-394)Gsu-3;  or (7) 
(A3-28/A353-384)Gsct-3 was 
incubated for 1 h at 25~  in 
homogenization  buffer  con- 
taining  1% cholate.  The mix- 
ture was centrifuged for I h at 
100,000 g to prepare pellet (P) and soluble (S) fractions which were analyzed by SDS-PAGE and immunoblot using RM antibody  for 
all samples except those in panel 6 for which GCL antibody was used. Antibody binding was detected by incubating the blot with l~25I]- 
protein A followed by autoradiography. 
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brane binding.  Substitution of this segment of Gset for the 
carboxyl-terminal 14 residues of Gila promoted membrane 
binding of  an otherwise soluble amino-terminal deletion mu- 
tant of Gil. 
In the present work, we sought to define the relative im- 
portance of amino and carboxy-terminal regions of Gsa in 
membrane binding. Our approach was to construct deletion 
mutant cDNAs,  transfect these acutely in COS cells,  and 
monitor expression in particulate vs. soluble fractions. Dele- 
tion of substantial portions of the amino terminus, carboxy 
terminus, or both (Fig.  1) was still compatible with expres- 
sion of stable protein in COS cells. In every case tested, the 
protein product was  localized primarily to the particulate 
fraction, and in similar proportion to the endogenous forms 
of Gset or to transfected wild type Gset cDNAs. These results 
are consistent with those of Audigier and coworkers (1, 20) 
for the amino terminal deletion mutants and for the carboxyl- 
terminal 385-394 deletion mutant (1, 21), but not for the 
353-384 and 353-394 deletion mutants. The latter encom- 
pass the putative site of V8 protease cleavage that led to re- 
lease of Gset from membranes (1) as well as the 367-376 
residues claimed to be critical for membrane association (21). 
There  are  several  possible  reasons  for  the  latter  dis- 
crepancy. The methods used to study membrane association 
are quite different. In the assay employed by Audigier and 
co-workers  in  vitro  translated  protein  is  incubated  with 
membranes which are then sedimented, and the proportion 
of membrane bound, labeled protein determined (19). Even 
for wild type Gset,  the proportion of protein that becomes 
membrane bound is substantially less than 100% (21).  The 
relationship between this assay and membrane targeting of 
intracellularly synthesized protein is not clear, although in 
vitro synthesized Gsa has been shown to be biologically ac- 
tive (30). It is also important to point out that the ability of 
residues 367-376 of Gsa to promote membrane association 
of soluble Gila does not prove that this region alone is criti- 
cal  for Gsa membrane binding.  Additional regions could 
also be important. The same authors did not directly assess 
the ability of forms of Gset deleted at the carboxy terminus 
to bind to membranes. 
Acute transfection of COS cells to monitor expression of 
mutant proteins has the advantage of more closely approx- 
imating intracellular synthesis and targeting, but this method 
too is far from physiologic in that proteins are often substan- 
tially  overexpressed,  and  could potentially be  aberrantly 
localized. Nevertheless, this method has been very useful in 
elucidating the critical role of myristoylation in membrane 
binding of certain Get subunits.  Mutation of Gila (18) or 
Goa (27) that precludes myristoylation leads to completely 
cytosolic  localization  of the  product  even  when  overex- 
pressed in COS cells. Thus, the fact that all the deletion mu- 
tants of Gset localized to the particulate fraction could indi- 
cate that Gsa membrane attachment is different from that of 
myristoylated et subunits in that several regions are critical 
for membrane binding. 
It is also possible, however, that particulate localization of 
the expressed proteins does not reflect specific plasma mem- 
brane association. Resistance of the deletion mutants of Gset 
to solubilization by alkali or sodium cholate may reflect lo- 
calization of these particular mutant forms of the protein to 
a relatively inaccessible compartment, or protein aggrega- 
tion.  Overexpression of Gset in Sf-9 cells using a  recom- 
binant baculovirus produced a protein found in the particu- 
late  fraction  that  was  resistant  to  solubilization  by  1% 
sodium cholate. This contrasts with various forms of Giet 
which when expressed in this system were localized to the 
cytosol or readily solubilized from the particulate fraction 
(15).  Since transient expression of et subunits in COS cells 
has  been used by many investigators to assess  G  protein 
function, the present results suggest that one must be cau- 
tious in correlating the appearance of immunoreactivity in 
the  particulate  fraction with  correct localization of func- 
tional protein to receptor/effector interaction sites. 
In summary, our results show that amino and carboxy ter- 
minal  deletion mutants  of Gset can be expressed in  COS 
cells, and they are localized to the particulate fraction. These 
results confirm that the amino terminus of Gsa is not critical 
for  membrane  binding,  but  leave  open  the  question  of 
whether the carboxy terminus, including residues 367-376, 
is critical in this respect. Additional studies are required to 
define the molecular basis for Gsa membrane targeting. 
We are grateful  to Dr. Regina M.  Collins for providing the COS-7 cells 
for transfection, to Dr. Cecille  Unson and Dr. Paul Goldsmith for peptides 
and antibodies,  and to Dr. John J.  Merendino Jr.  for helpful  discussions 
and review of the paper. 
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